Raymond James & Associates Chroma Dex Corp. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding CDXC
# of Institutions
94Shares Held
17.2MCall Options Held
66.7KPut Options Held
8.2K-
Vanguard Group Inc Valley Forge, PA3.43MShares$26.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$23.8 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.96MShares$22.6 Million5.59% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$9.9 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$8.78 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $522M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...